Literature DB >> 34019168

Ethical Challenges in Pediatric Oncology Care and Clinical Trials.

Daniel J Benedetti1, Jonathan M Marron2.   

Abstract

The care of pediatric cancer patients is a vast departure from cancer care of adults. While the available treatment modalities-chemotherapy, radiation, and surgery-are the same, the diseases, care-delivery, and outcomes differ greatly. And just as 'children are not just little adults,' pediatric bioethics occupies a distinct place within the broader field of bioethics. In this chapter, we will begin with an introduction to fundamental principles and frameworks for understanding ethical issues in pediatrics, highlighting the triadic nature of medical decision-making between a physician, the child-patient, and the child's parent as the surrogate decision-maker. We will then delve into further details of how these principles and frameworks shape the care of children with cancer, examining specific ethical challenges commonly encountered by pediatric oncologists. We will traverse this landscape by examining issues involving (a) informed consent; (b) research involving children; (c) end of life; (d) genetic and genomic testing; and (e) professionalism. We also examine ethical challenges in clinical research, in children and more broadly. While not an exhaustive exploration of the myriad ethical issues one might encounter in pediatric cancer medicine and clinical trials, this chapter provides readers with a foundation for further reading.

Entities:  

Keywords:  Clinical research; Emerging autonomy; Incidental findings; Palliative sedation; Pediatric bioethics; Pediatric oncology; Precision oncology; Right to try; Surrogate decision-making; Treatment refusal; Truth-telling

Year:  2021        PMID: 34019168     DOI: 10.1007/978-3-030-63749-1_11

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  58 in total

Review 1.  Clinical practice. Assessment of patients' competence to consent to treatment.

Authors:  Paul S Appelbaum
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

Review 2.  Futility: a concept in evolution.

Authors:  Jeffrey P Burns; Robert D Truog
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

3.  Harmonization of ethics policies in pediatric research.

Authors:  Valarie Blake; Steve Joffe; Eric Kodish
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

4.  An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units.

Authors:  Gabriel T Bosslet; Thaddeus M Pope; Gordon D Rubenfeld; Bernard Lo; Robert D Truog; Cynda H Rushton; J Randall Curtis; Dee W Ford; Molly Osborne; Cheryl Misak; David H Au; Elie Azoulay; Baruch Brody; Brenda G Fahy; Jesse B Hall; Jozef Kesecioglu; Alexander A Kon; Kathleen O Lindell; Douglas B White
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

Review 5.  The legal authority of mature minors to consent to general medical treatment.

Authors:  Doriane Lambelet Coleman; Philip M Rosoff
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

6.  Communicating and understanding the purpose of pediatric phase I cancer trials.

Authors:  Melissa K Cousino; Stephen J Zyzanski; Amy D Yamokoski; Rebecca A Hazen; Justin N Baker; Robert B Noll; Susan R Rheingold; J Russell Geyer; Stewart C Alexander; Dennis Drotar; Eric D Kodish
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

7.  Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling.

Authors:  Barrie Cohen; Michael Roth; Jonathan M Marron; Stacy W Gray; David S Geller; Bang Hoang; Richard Gorlick; Katherine A Janeway; Jonathan Gill
Journal:  Ann Surg Oncol       Date:  2016-07-26       Impact factor: 5.344

8.  MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.

Authors:  Wendy Chang; Andrew S Brohl; Rajesh Patidar; Sivasish Sindiri; Jack F Shern; Jun S Wei; Young K Song; Marielle E Yohe; Berkley Gryder; Shile Zhang; Kathleen A Calzone; Nityashree Shivaprasad; Xinyu Wen; Thomas C Badgett; Markku Miettinen; Kip R Hartman; James C League-Pascual; Toby N Trahair; Brigitte C Widemann; Melinda S Merchant; Rosandra N Kaplan; Jimmy C Lin; Javed Khan
Journal:  Clin Cancer Res       Date:  2016-03-18       Impact factor: 12.531

Review 9.  Recommendations for returning genomic incidental findings? We need to talk!

Authors:  Wylie Burke; Armand H Matheny Antommaria; Robin Bennett; Jeffrey Botkin; Ellen Wright Clayton; Gail E Henderson; Ingrid A Holm; Gail P Jarvik; Muin J Khoury; Bartha Maria Knoppers; Nancy A Press; Lainie Friedman Ross; Mark A Rothstein; Howard Saal; Wendy R Uhlmann; Benjamin Wilfond; Susan M Wolf; Ron Zimmern
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

Review 10.  Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review.

Authors:  Loredana Covolo; Sara Rubinelli; Elisabetta Ceretti; Umberto Gelatti
Journal:  J Med Internet Res       Date:  2015-12-14       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.